NCT01030276Unknown不适用
Placebo-controlled, Double Blind RCT on the Efficacy of Bright Light Therapy in SAD
适应症
干预措施
试验速览
- 阶段
- 不适用
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- Remission as defined by the SIGH-SAD
研究概览
简要总结
The aim of this study is to investigate the efficacy of bright light therapy in SAD. This is a placebo-controlled, double-blind randomized controlled trial (RCT).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Triple (Participant, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •a patient has, according to the DSM-IV-TR, a Major depression, recurrent episode, seasonal pattern, "moderate" or "severe" (classification code 296.32 and 296.33)
- •HAMD-21 (included in the SIGH-SAD) sum score is ≥ 22
- •patient is over 18 years
- •patient can read and understand the subject information sheet
- •patient has signed the informed consent form
- •patient is not pregnant
排除标准
- •patient has a lifetime psychotic disorder
- •patient has a DSM-IV Axis I disorder other than some anxiety disorder evaluated by MINI
- •patient has some DSM-IV-TR Axis II disorder, which is likely to interfere with the study treatment according to the investigator
- •patient has alcohol or some other substance use dependence or misuse
- •life-time suicide attempt, or any thought of suicide during the last month
- •patients has some unstable somatic disorder
- •patient uses some medication on regular basis
- •patient uses some herbal psychotropic agencies
- •patient is, in the opinion of the investigator, unsuitable for any reason
- •patient is a member of the site personnel or their immediate families
- •patient has had bright light therapy during the current episode
- •patient has some eye disease (patient can, however, be myopic or hyperopic)
研究组 & 干预措施
Bright light
Experimental
干预措施: Bright light therapy (Other)
Inactive "placebo-light"
Placebo Comparator
干预措施: Inactive "placebo-light" (Other)
结局指标
主要结局
Remission as defined by the SIGH-SAD
时间窗: 28 (visit window from 26 to 30 days) days after the inclusion day
次要结局
- Decrease of the severity of symptoms as assessed by SIGH-SAD, Hamilton anxiety scale, and Beck depression inventory-21(28 (visit window from 26 to 30 days) days)
研究者
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Impact of Bright Light Therapy on Prader-Willi SyndromePrader-Willi SyndromeBehaviorHyperphagiaBody WeightExcessive Daytime SleepinessMoodNCT05939453Maimonides Medical Center50
Unknown
不适用
Clinical Trial of Light Therapy for EpilepsyEpilepsyNCT01028456University College, London100
已完成
不适用
Light Therapy for Depression During PregnancyPregnancyMajor Depressive DisorderNCT01043289Psychiatric Hospital of the University of Basel46
已完成
不适用
Bright Light Therapy for Non-motor Symptoms in Parkinson's DiseaseParkinson DiseaseNCT05524961Chinese University of Hong Kong69
Unknown
不适用
Light Therapy in Disorders of Consciousness: Behavioral, Neuroimaging and (Neuro)Physiological Assessments.Disorder of ConsciousnessNCT03174119University of Liege50